NRX Pharmaceuticals Warrant
NRXPW
NRXPW was delisted on the 22nd of May, 2026.
4 hedge funds and large institutions have $2.84K invested in NRX Pharmaceuticals Warrant in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
33% more funds holding
Funds holding: 3 → 4 (+1)
0.01% less ownership
Funds ownership: 0.03% → 0.02% (-0.01%)
5% less capital invested
Capital invested by funds: $2.99K → $2.84K (-$156)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.97K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$10 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
YCM
Yakira Capital Management
Westport,
Connecticut
|
-$2K |
| 2 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$808 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $2.42K | +$1.97K | +13,436 | New |
|
|
WAM
2
Wolverine Asset Management
Chicago,
Illinois
| $404 | -$808 | -5,500 | -72% |
|
|
3
UBS Group
Zurich,
Switzerland
| $13 | +$10 | +69 | New |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $3 | – | – | – |
|
|
YCM
5
Yakira Capital Management
Westport,
Connecticut
| – | -$2K | -15,409 | Closed |
|
NRXPW Hedge Fund Activity: Q1 2024 in Review
4 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in NRX Pharmaceuticals Warrant (NRXPW) for Q1 2024, worth a combined $2.84K — down 5.2% from $2.99K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new NRXPW positions and 1 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $1.97K. The largest seller was Yakira Capital Management, exiting entirely with an estimated $2K sold.
- 4 institutional investors held NRX Pharmaceuticals Warrant (NRXPW) as of Q1 2024, up from 3 in Q4 2023.
- Funds reported $2.84K of NRX Pharmaceuticals Warrant stock for Q1 2024, down 5.2% quarter-over-quarter.
- 2 funds opened new NRX Pharmaceuticals Warrant positions in Q1 2024 and 1 closed out, a net change of +1 holder.
- The largest NRX Pharmaceuticals Warrant buyer in Q1 2024 was Susquehanna International Group, an estimated $1.97K added.
- The largest NRX Pharmaceuticals Warrant seller in Q1 2024 was Yakira Capital Management, an estimated $2K sold.
Based on aggregated 13F filings for Q1 2024.